Plasmalogen attenuates the development of hepatic steatosis and cognitive deficit through mechanism involving p75NTR inhibition

Emerging evidence suggests that the reduction of ethanolamine plasmalogen (PlsEtn) is associated with in Alzheimer's disease and metabolic diseases. However, the mechanistic bases for PlsEtn on the these diseases are not well understood. Plasmalogens are primarily synthesized in the liver and e...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yanjun, Cong, Peixu, Zhang, Tao, Wang, Rui, Wang, Xiaoxu, Liu, Junyi, Wang, Xinceng, Xu, Jie, Wang, Yuming, Wang, Jingfeng, Xue, Changhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134739/
https://www.ncbi.nlm.nih.gov/pubmed/33984602
http://dx.doi.org/10.1016/j.redox.2021.102002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134739/
https://www.ncbi.nlm.nih.gov/pubmed/33984602
http://dx.doi.org/10.1016/j.redox.2021.102002

Ejemplares similares